CAS 53802-03-2: C.I. Solvent Red 109

6-Fluoro-3-indoxyl-beta-D-galactopyranoside, also known as Rifapentine, is a highly effective antituberculosis drug from the class of rifamycins. It is specifically designed to combat tuberculosis infections by targeting the active compounds in Mycobacterium tuberculosis strains. Rifapentine works by inhibiting bacterial growth through its bactericidal activity. By binding to DNA-dependent RNA polymerase, it prevents transcription and replication, effectively stopping the spread of the infection. This powerful drug has been extensively studied and proven to be highly active against tuberculosis. Its efficacy has been demonstrated using advanced techniques such as transcription-quantitative polymerase chain reaction and patch-clamp technique on human erythrocytes. Moreover, Rifapentine undergoes various metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucur